ReproNovo raised €57M in a Series A round in May 2025. The company is based in Lausanne, Switzerland. Investors in the round: ALSA Ventures, AXA IM Alts, Jeito Capital and 2 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €57M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.